Economy

Teva Pharmaceutical Industries Limited (TEVA) Upgraded to Sell by BidaskClub

Bronfman E.L. Rothschild L.P. now owns 3,711 shares of the company's stock valued at $123,000 after buying an additional 94 shares during the last quarter.

Want to see what other hedge funds are holding TEVA? Capital Research Global Investors boosted its stake in shares of Teva Pharmaceutical Industries Limited by 13.8% during the second quarter. Capital Research Global Investors now owns 76,325,059 shares of the company's stock valued at $2,535,518,000 after purchasing an additional 9,260,426 shares during the period.

ILLEGAL ACTIVITY NOTICE: "Teva Pharmaceutical Industries Limited (NYSE:TEVA) Earning Somewhat Positive News Coverage, Accern Reports" was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. Teva Pharmaceutical Industries Limited's payout ratio is -15.36%. Security National Bank of Sioux City Iowa IA lifted its position in shares of Teva Pharmaceutical Industries Limited by 0.4% during the 2nd quarter. Alliancebernstein L.P. now owns 11,399,400 shares of the company's stock valued at $378,688,000 after purchasing an additional 2,782,257 shares during the period. 4,114,947 shares of the company's stock traded hands. (NASDAQ:HAS), its shares were trading at $94.92 a retreat of $-0.88, on the trading floor. Teva Pharma has $86 highest and $14 lowest target. The stock has a 50 day moving average of $20.60 and a 200 day moving average of $28.94. The company's market capitalization is $19.64 billion. Barclays Capital maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, August 7 with "Equal-Weight" rating. The company reported $1.38 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.36 by $0.02. The business had revenue of $5.69 billion during the quarter, compared to analysts' expectations of $5.72 billion. Teva Pharmaceutical Industries Limited had a negative net margin of 25.18% and a positive return on equity of 15.96%. Teva Pharmaceutical Industries Limited's revenue for the quarter was up 12.9% on a year-over-year basis. Equities analysts anticipate that Teva Pharmaceutical Industries Limited will post $4.32 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 14th. The rating was downgraded by Susquehanna on Tuesday, September 6 to "Neutral". This represents a $0.34 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Tuesday, February 28th.

A number of research firms recently issued reports on TEVA. Cantor Fitzgerald set a $31.00 target price on Teva Pharmaceutical Industries Limited and gave the stock a "hold" rating in a research note on Thursday, June 22nd. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since September 13, 2016 and is downtrending.

In a research report revealed to clients earlier today, BTIG Research raised Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE:TEVA) shares to a solid "Buy" rating from their previous "Neutral" rating and they now have a $24 target on shares.

Shares of Teva Pharmaceutical Industries Limited (NYSE TEVA) opened at 19.33 on Wednesday. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and sixteen have assigned a buy rating to the company's stock. If you are viewing this piece on another publication, it was illegally copied and republished in violation of worldwide copyright law. The correct version of this report can be read at https://stocknewstimes.com/2017/09/13/teva-pharmaceutical-industries-limited-teva-shares-bought-by-schroder-investment-management-group.html.

According to the Complaint, throughout the Class Period, Teva made false and/or misleading statements and/or failed to disclose that the poor performance of its US generics business resulted in recording a goodwill impairment charge related to the acquisition of Actavis Generics and was a key factor in cutting the Company's dividend by 75%. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines.



Like this

Latest


14 September 2017
Analysts Anticipate Helix Energy Solutions Group, Inc. (HLX) to Announce $0.02 EPS
Following the completion of the sale, the insider now owns 273,360 shares in the company, valued at approximately $2,531,313.60. Princeton Alpha Management LP grew its holdings in shares of Helix Energy Solutions Group by 4.8% during the first quarter.

14 September 2017
Applied Genetic Technologies Corporation (AGTC) Under Analyst Spotlight
Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The Company develops gene therapy products created to manage the lives of patients with severe diseases in ophthalmology.

14 September 2017
Aberdeen Asset Management PLC UK Trims Stake in Discovery Communications, Inc. (DISCK)
Ltd. now owns 36,348 shares of the company's stock worth $1,029,000 after buying an additional 979 shares during the last quarter. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of worldwide copyright laws.

14 September 2017
Myanmar envoy blames Rohingya insurgents for violence in Rakhine state
A group of people today took out a protest march here and condemned the violence against Rohingya Muslims in Myanmar. Dubai's ruler is sending a Boeing 747 cargo plane loaded with tents to shelter Rohingya refugees in Bangladesh.

14 September 2017
NXP Semiconductors NV (NXPI) Position Cut by Commerzbank Aktiengesellschaft FI
Towle & Co decreased its stake in Titan Machinery Inc (TITN) by 36.38% based on its latest 2016Q4 regulatory filing with the SEC. It is positive, as 40 investors sold PRU shares while 258 reduced holdings. 23 funds opened positions while 69 raised stakes.

14 September 2017
Associated Banc Corp Has $5.09 Million Holdings in Zoetis Inc. (ZTS)
In other Zoetis news, insider Roxanne Lagano sold 9,797 shares of the firm's stock in a transaction on Tuesday, November 8th. The company reported $0.53 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.53.

14 September 2017
Hillary: Okay, I made mistakes … but what about Comey and the misogyny?
She also expressed that voter identification laws, which she labeled "voter suppression", was also responsible for her loss. "She's going to get locked up, '" Clinton told Vox's Ezra Klein on Tuesday.

14 September 2017
Another massive cameo for 'Star Wars: The Last Jedi' has been confirmed
Newcomers are Benicio Del Toro as "DJ", Laura Dern as Vice Admiral Amilyn Holdo, and Kelly Marie Tran as Rose. The Last Jedi hits theaters this December 15th, which can not arrive soon enough.

14 September 2017
Broderick Brian C Increases Holdings in Microsoft Corporation (MSFT)
Gierl Augustine Investment Management Inc lifted its position in shares of Microsoft Corporation by 0.3% in the first quarter. Los Angeles Cap Mgmt And Equity Research Inc holds 0% of its portfolio in Graham Corporation (NYSE:GHM) for 10,958 shares.

14 September 2017
Suit: Loose Lid on 'Extra Hot' Tea Killed Starbucks Customer's Dog
As Salas-Solano allegedly cried out in pain, she says her dog Alexander jumped on to her lap, causing her to spill tea on him too. In the video, it's hard to tell if Salas-Solano grabs the cup by the hot sleeve or by the lid when she accidentally spilled it.



Recommended